{
    "clinical_study": {
        "@rank": "23413", 
        "acronym": "ADC", 
        "brief_summary": {
            "textblock": "The main objective of the study is to assess the sensitivity and the specificity of the\n      variation of apparent diffusion coefficient for prediction, after a course of neoadjuvant\n      chemotherapy or after modification of the treatment sequence, the pathological response at\n      the end of chemotherapy"
        }, 
        "brief_title": "Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Assess the Variation of Apparent Diffusion Coefficient", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age> 18 years.\n\n          -  Patient suffering from a breast tumor, regardless of the stage and size\n\n          -  Patient requiring neoadjuvant chemotherapy\n\n          -  Patient has the ability to undergo 18F-FDG-PET at baseline, at end of cycle 1 and at\n             the end of neoadjuvant treatment before surgery\n\n          -  Compulsory affiliation to a social security system.\n\n          -  Obtaining informed consent in writing, signed and dated.\n\n        Exclusion Criteria:\n\n          -  Patient with cognitive or psychiatric disorders.\n\n          -  Patient deprived of liberty by a court or administrative.\n\n          -  Patient with signs against the achievement of MRI, mammography and ultrasound\n\n          -  Patient metastatic\n\n          -  Patient with prior chemotherapy, radiotherapy and hormone therapy for her breast\n             cancer\n\n          -  Pregnant women, current lactation\n\n          -  Patient suffering from uncontrolled diabetes (> 11 mmol / L)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01956513", 
            "org_study_id": "Etude ADC"
        }, 
        "intervention": {
            "description": "MRI will be realised at the beginning of the study, after a cycle of chemotherapy or at changement of sequence and at the end of chemotherapy.", 
            "intervention_name": "MRI (Magnetic resonance imaging)", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ADC", 
            "breast cancer", 
            "complete pathological response"
        ], 
        "lastchanged_date": "October 7, 2013", 
        "number_of_arms": "1", 
        "official_title": "Etude ADC Apport de l'IRM Dans l'\u00e9valuation du Coefficient de Diffusion Apparent et pr\u00e9diction de la r\u00e9ponse \u00e0 la chimioth\u00e9rapie n\u00e9oadjuvante Dans le Cancer du Sein", 
        "overall_official": {
            "affiliation": "Centre Jean Perrin", 
            "last_name": "Anne BAILLY, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Variation of apparent diffusion coefficient before / after a cycle of neoadjuvant chemotherapy or before / after modification of the treatment sequence and correlated with histologic response", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01956513"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Jean Perrin", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Jean Perrin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013", 
        "why_stopped": "We have finally no financial support and any patients have been included."
    }
}